![Prem Premsrirut](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Prem Premsrirut
Chief Executive Officer at Mirimus, Inc.
Prem Premsrirut active positions
Companies | Position | Start | End |
---|---|---|---|
New York Biotechnology Association, Inc.
![]() New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Director/Board Member | - | - |
Mirimus, Inc.
![]() Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | Chief Executive Officer | 01/01/2010 | - |
Founder | 01/01/2010 | - | |
President | 01/01/2010 | - |
Career history of Prem Premsrirut
Statistics
International
United States | 3 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectoral
Commercial Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
New York Biotechnology Association, Inc.
![]() New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Commercial Services |
Mirimus, Inc.
![]() Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | Health Technology |
- Stock Market
- Insiders
- Prem Premsrirut
- Experience